Sai Parenteral's
SAIPARENTNSE

Sai Parenteral's

₹516.504.25 (0.83%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
509.00
Today’s high
519.50
52 week low
400.00
52 week high
543.20
Open price
514.90
Previous close
512.25
Live volume
80,472
Lower circuit
409.80
Upper circuit
614.70

Financial performance

No data available

Financials data is not available for this period

About

Sai Parenterals is a diversified pharmaceutical formulations company. While it started as a specialist in "parenterals" (injectables), it has evolved into a multi-dosage platform. Its business is split into two main verticals:Branded Generic Formulations and CDMO (Contract Development and Manufacturing). The company covers high-growth therapeutic areas such as cardiovascular, anti-diabetic, neuropsychiatry, and oncology. It operates five manufacturing facilities—four in Hyderabad (Telangana) and one in Ongole (Andhra Pradesh).;
CEO/MD
Mr. Anil Kumar Karusala
Founded in
2001
NSE symbol
SAIPARENT

Shareholding Pattern

Sep '25
Mar '26
Apr '26
Promoters
51.16%
Retail And Others
28.14%
Other Domestic Institutions
9.05%
Foreign Institutions
7.85%
Mutual Funds
3.81%

Mutual Funds Invested (1)

Livesquawk
Sai Parenterals plans FY27 capex: ₹118 Cr for India expansion, EU-GMP upgrades. AUD 53 Mn for Australia's largest pharma plant, ₹18 Cr for R&D center.
Livesquawk
Sai Parenterals targets Rs 750 crore revenue for FY27, per MD. The company aims to achieve EBITDA margin expansion up to 17%.
Livesquawk
Sai Parenterals shares debuted on BSE at Rs 405, 3.3% above issue price.
2026
23
May
Quarterly & Annual Result
Release date
Events calendar
View upcoming events in other stocks